92 related articles for article (PubMed ID: 1728268)
1. Intra-arterial cisplatin--associated optic and otic toxicity.
Maiese K; Walker RW; Gargan R; Victor JD
Arch Neurol; 1992 Jan; 49(1):83-6. PubMed ID: 1728268
[TBL] [Abstract][Full Text] [Related]
2. Visual system toxicity following intra-arterial chemotherapy.
Kupersmith MJ; Frohman LP; Choi IS; Foo SH; Hiesinger E; Berenstein A; Wise A; Carr RE; Ransohoff J
Neurology; 1988 Feb; 38(2):284-9. PubMed ID: 3340295
[TBL] [Abstract][Full Text] [Related]
3. Neurophysiological and neuro-otological study of homozygous beta-thalassemia under long-term desferrioxamine (DFO) treatment.
Triantafyllou N; Fisfis M; Sideris G; Triantafyllou D; Rombos A; Vrettou H; Mantouvalos V; Politi C; Malliara S; Papageorgiou C
Acta Neurol Scand; 1991 May; 83(5):306-8. PubMed ID: 1648295
[TBL] [Abstract][Full Text] [Related]
4. Intra-arterial cisplatin in malignant brain tumors: incidence and severity of otic toxicity.
Assietti R; Olson JJ
J Neurooncol; 1996 Mar; 27(3):251-8. PubMed ID: 8847559
[TBL] [Abstract][Full Text] [Related]
5. Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions.
Olivieri NF; Buncic JR; Chew E; Gallant T; Harrison RV; Keenan N; Logan W; Mitchell D; Ricci G; Skarf B
N Engl J Med; 1986 Apr; 314(14):869-73. PubMed ID: 3485251
[TBL] [Abstract][Full Text] [Related]
6. Sensory evoked potentials in inhalant (volatile solvent) abuse.
Tenenbein M; Pillay N
J Paediatr Child Health; 1993 Jun; 29(3):206-8. PubMed ID: 8518004
[TBL] [Abstract][Full Text] [Related]
7. Maculopathy caused by intra-arterially administered cisplatin and intravenously administered carmustine.
Kupersmith MJ; Seiple WH; Holopigian K; Noble K; Hiesiger E; Warren F
Am J Ophthalmol; 1992 Apr; 113(4):435-8. PubMed ID: 1558119
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of nervous system disorders during the course of gastric carcinoma on the basis of clinical electrophysiologic analysis].
Fabian A
Ann Acad Med Stetin; 1999; 45():175-93. PubMed ID: 10909489
[TBL] [Abstract][Full Text] [Related]
9. Retinal toxicity after high-dose cisplatin therapy.
Wilding G; Caruso R; Lawrence TS; Ostchega Y; Ballintine EJ; Young RC; Ozols RF
J Clin Oncol; 1985 Dec; 3(12):1683-9. PubMed ID: 4067616
[TBL] [Abstract][Full Text] [Related]
10. Ocular and auditory toxicity in hemodialyzed patients receiving desferrioxamine.
Cases A; Kelly J; Sabater F; Torras A; Griño MC; Lopez-Pedret J; Revert L
Nephron; 1990; 56(1):19-23. PubMed ID: 2234245
[TBL] [Abstract][Full Text] [Related]
11. Visual evoked potentials in the detection of subclinical optic toxic effects secondary to ethambutol.
Yiannikas C; Walsh JC; McLeod JG
Arch Neurol; 1983 Oct; 40(10):645-8. PubMed ID: 6615272
[TBL] [Abstract][Full Text] [Related]
12. Does intracochlear brain-derived nerve growth factor improve auditory brainstem click thresholds in sensorineural hearing loss?
Meen E; Blakley B; Quddusi T
J Otolaryngol Head Neck Surg; 2010 Jun; 39(3):232-5. PubMed ID: 20470666
[TBL] [Abstract][Full Text] [Related]
13. Sensory-evoked potentials: measures of neurotoxicity.
Boyes WK
NIDA Res Monogr; 1993; 136():63-98; discussion 98-100. PubMed ID: 8289915
[No Abstract] [Full Text] [Related]
14. Preventing cisplatin induced ototoxicity by N-acetylcysteine and salicylate.
Yıldırım M; Inançlı HM; Samancı B; Oktay MF; Enöz M; Topçu I
Kulak Burun Bogaz Ihtis Derg; 2010; 20(4):173-83. PubMed ID: 20626325
[TBL] [Abstract][Full Text] [Related]
15. Acute visual and auditory neurotoxicity in patients with end-stage renal disease receiving desferrioxamine.
Cases A; Kelly J; Sabater J; Campistol JM; Torras A; Montoliu J; López I; Revert L
Clin Nephrol; 1988 Apr; 29(4):176-8. PubMed ID: 3365862
[TBL] [Abstract][Full Text] [Related]
16. Left-right asymmetry in hearing loss following cisplatin therapy in children--the left ear is slightly but significantly more affected.
Schmidt CM; Knief A; Lagosch AK; Deuster D; am Zehnhoff-Dinnesen A
Ear Hear; 2008 Dec; 29(6):830-7. PubMed ID: 18772725
[TBL] [Abstract][Full Text] [Related]
17. Two-year follow-up of two patients after severe thallium intoxication.
Pelclová D; Urban P; Ridzon P; Senholdová Z; Lukás E; Diblík P; Lacina L
Hum Exp Toxicol; 2009 May; 28(5):263-72. PubMed ID: 19755458
[TBL] [Abstract][Full Text] [Related]
18. Visual toxicity following intra-arterial chemotherapy with hydroxyethyl-CNU in patients with malignant gliomas. A prospective study with statistical analysis.
Defer G; Fauchon F; Schaison M; Chiras J; Brunet P
Neuroradiology; 1991; 33(5):432-7. PubMed ID: 1749475
[TBL] [Abstract][Full Text] [Related]
19. Neurophysiological assessment of auditory, peripheral nerve, somatosensory, and visual system functions after developmental exposure to ethanol vapors.
Boyes WK; Degn LL; Martin SA; Lyke DF; Hamm CW; Herr DW
Neurotoxicol Teratol; 2014; 43():1-10. PubMed ID: 24607749
[TBL] [Abstract][Full Text] [Related]
20. Evoked potentials in cerebrotendinous xanthomatosis and effect induced by chenodeoxycholic acid.
Mondelli M; Rossi A; Scarpini C; Dotti MT; Federico A
Arch Neurol; 1992 May; 49(5):469-75. PubMed ID: 1316120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
